Compare BridgeBio Pharma Inc (BBIO) vs Eos Energy Enterprises Inc (EOSE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Eos Energy Enterprises Inc — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Eos Energy Enterprises Inc trades at $4.32 (market cap $1.54B). The key difference: BridgeBio Pharma Inc is far larger — about 10.6× Eos Energy Enterprises Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Eos Energy Enterprises Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | EOSE | |
|---|---|---|
Market Cap | $16.27B | $1.54B |
Sector | Health | Energy |
52-Week High | $90.17 | $19.19 |
52-Week Low | $44.81 | $4.29 |
Enterprise Value | $17.82B | $1.78B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Eos Energy Enterprises Inc
Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →
